Depression and Anxiety Trial, Recruiting (NCT05772897)

Depression and Anxiety Trial, Recruiting NCT05772897 Sponsor: University of Colorado, Denver Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT05772897 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Mothers between 18 and 50 years old who have a baby aged 3 to 14 months old
Both mothers who are experiencing signs of depression and mothers who are not experiencing depression are welcome to take part
Note: If a mother is showing signs of active depression and is not already receiving professional treatment (such as therapy or medication), the trial team will refer her to appropriate care before she is enrolled. This trial is not a substitute for professional mental health treatment.

Who may not be able to join:

Mothers who have been diagnosed with a serious mental health condition, such as bipolar disorder, schizophrenia, or a personality disorder, among others
Babies who have significant health problems that may affect the mother's ability to take part in or benefit from the program

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sunny Stophaeros, MS, sunny.stophaeros@ucdenver.edu

Phone: 9253392971

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05772897

Sponsor: University of Colorado, Denver

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: 9253392971

More information: https://clinicaltrials.gov/study/NCT05772897

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Mothers between 18 and 50 years old who have a baby aged 3 to 14 months old
Both mothers who are experiencing signs of depression and mothers who are not experiencing depression are welcome to take part
Note: If a mother is showing signs of active depression and is not already receiving professional treatment (such as therapy or medication), the trial team will refer her to appropriate care before she is enrolled. This trial is not a substitute for professional mental health treatment.

Who may not be able to join:

Mothers who have been diagnosed with a serious mental health condition, such as bipolar disorder, schizophrenia, or a personality disorder, among others
Babies who have significant health problems that may affect the mother's ability to take part in or benefit from the program

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Colorado, Denver

Registry

ClinicalTrials.gov

Start date

3 August 2023

Est. completion

1 April 2035

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in methylation of OXTR receptor gene rs53576; Changes in Beck Depression Inventory, Second Edition (BDI-II) Score; Changes Postpartum Depression Screening Scale (PDSS) Score; Changes in Dyadic Adjustment Scale (DAS) Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov